Clinical Trial Update: A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments [Phase 2]

View source ↗

Summary

Phase 2 trial comparing best supportive care plus E7080 versus best supportive care alone in previously treated advanced non-small cell lung cancer; study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• E7080 (lenvatinib)

Snippet

Sponsor: Eisai Inc. | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-02-18